Pacific Center for Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $167K | Hold |
2,757
| – | – | 0.04% | 105 |
|
|
2025
Q4 | $124K | Hold |
2,757
| – | – | 0.03% | 122 |
|
|
2025
Q3 | $124K | Hold |
2,757
| – | – | 0.03% | 122 |
|
|
2025
Q2 | $128K | Hold |
2,757
| – | – | 0.03% | 122 |
|
|
2025
Q1 | $168K | Hold |
2,757
| – | – | 0.04% | 106 |
|
|
2024
Q4 | $156K | Hold |
2,757
| – | – | 0.04% | 106 |
|
|
2024
Q3 | $143K | Hold |
2,757
| – | – | 0.04% | 113 |
|
|
2024
Q2 | $114K | Hold |
2,757
| – | – | 0.03% | 125 |
|
|
2024
Q1 | $150K | Hold |
2,757
| – | – | 0.04% | 107 |
|
|
2023
Q4 | $141K | Hold |
2,757
| – | – | 0.04% | 104 |
|
|
2023
Q3 | $160K | Hold |
2,757
| – | – | 0.05% | 91 |
|
|
2023
Q2 | $176K | Hold |
2,757
| – | – | 0.06% | 88 |
|
|
2023
Q1 | $191K | Buy |
+2,757
| New | +$194K | 0.07% | 79 |
|
|
2022
Q3 | $196K | Hold |
2,757
| – | – | 0.08% | 75 |
|
|
2022
Q2 | $212K | Hold |
2,757
| – | – | 0.09% | 74 |
|
|
2022
Q1 | $201K | Sell |
2,757
-5
| -0.2% | -$336 | 0.07% | 74 |
|
|
2021
Q4 | $172K | Hold |
2,762
| – | – | 0.07% | 79 |
|
|
2021
Q3 | $163K | Hold |
2,762
| – | – | 0.07% | 77 |
|
|
2021
Q2 | $185K | Hold |
2,762
| – | – | 0.08% | 72 |
|
|
2021
Q1 | $174K | Hold |
2,762
| – | – | 0.08% | 71 |
|
|
2020
Q4 | $171K | Buy |
2,762
+567
| +26% | +$34.9K | 0.06% | 69 |
|
|
2020
Q3 | $132K | Hold |
2,195
| – | – | 0.05% | 68 |
|
|
2020
Q2 | $129K | Hold |
2,195
| – | – | 0.06% | 69 |
|
|
2020
Q1 | $122K | Sell |
2,195
-400
| -15% | -$24.4K | 0.08% | 66 |
|
|
2019
Q4 | $167K | Buy |
2,595
+5
| +0.2% | +$286 | 0.07% | 62 |
|
|
2019
Q3 | $131K | Hold |
2,590
| – | – | 0.06% | 75 |
|
|
2019
Q2 | $117K | Hold |
2,590
| – | – | 0.06% | 75 |
|
|
2019
Q1 | $124K | Hold |
2,590
| – | – | 0.07% | 69 |
|
|
2018
Q4 | $135K | Hold |
2,590
| – | – | 0.07% | 64 |
|
|
2018
Q3 | $161K | Hold |
2,590
| – | – | 0.08% | 64 |
|
|
2018
Q2 | $143K | Hold |
2,590
| – | – | 0.08% | 67 |
|
|
2018
Q1 | $164K | Hold |
2,590
| – | – | 0.1% | 60 |
|
|
2017
Q4 | $159K | Hold |
2,590
| – | – | 0.1% | 62 |
|
|
2017
Q3 | $165K | Hold |
2,590
| – | – | 0.11% | 57 |
|
|
2017
Q2 | $144K | Hold |
2,590
| – | – | 0.1% | 62 |
|
|
2017
Q1 | $141K | Buy |
2,590
+185
| +8% | +$10.1K | 0.1% | 61 |
|
|
2016
Q4 | $141K | Buy |
+2,405
| New | +$131K | 0.11% | 59 |
|
Other funds holding BMY
VCM
VPM
Pacific Center for Financial Services's BMY Position: Q1 2026 in Review
Pacific Center for Financial Services held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 2,757 shares worth $167K. The position accounts for 0.04% of the portfolio, ranked #105.
Pacific Center for Financial Services first reported a position in BMY in Q4 2016 and has held it in 37 quarters since. The position peaked at $212K in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Pacific Center for Financial Services held 2,757 shares of Bristol-Myers Squibb worth $167K as of Q1 2026.
- Pacific Center for Financial Services left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.04% of Pacific Center for Financial Services's portfolio in Q1 2026, its #105 holding.
- Pacific Center for Financial Services first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 37 quarters since.
- Pacific Center for Financial Services's Bristol-Myers Squibb position peaked at $212K in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Pacific Center for Financial Services's 13F filing for Q1 2026, filed 12 May 2026.